Skip to main content

Table 6 The relationship between selected protein concentration and other parameters

From: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study

Table 6. Hypertension ALP ↑ CRP ↑ Fe ↓ ↑ inorganic P ↑ Uric acid ↑ Urea
Fetuin A [ng/ml] 112.1±74.3 168.9±65.74 108.7±74.5 115.6±77.3 106.4±69.2 114.1±83.3 120.7±73.6
MMP-2 [ng/ml] 217.8±150.92 225.4±82.0 229.4±116.15 232.1±158.9 240.2±134.0 264.1±163.81 227.7±132.84
MMP-9 [ng/ml] 18.3±6.5 17.9±7.2 19.0±7.0 17.8±6.3 17.4±6.9 19.6±5.64 18.0±7.0
TIMP-1 [ng/ml] 21.5±2.7 21.1±2.2 21.4±2.2 21.8±2.4 21.3±2.1 20.9±2.54 21.5±2.4
MMP-2/TIMP-2 9.8±6.83 10.4±3.4 10.6±5.64 10.5±6.8 11.2±6.6 11.6±7.41 10.3±6.24
MMP-9/TIMP-1 0.84±0.35 0.86±0.41 0.88±0.39 0.83±0.33 0.82±0.37 0.91±0.316 0.83±0.41
Osteocalcin [ng/ml] 5.9±4.1 3.2±3.2 4.9±4.35 5.0±4.7 4.1±3.64 5.6±3.6 4.9±4.11
Osteopontin [ng/ml] 26.3±26.13 17.6±7.7 25.9±20.9 32.4±31.1 31.4±25.1 26.4±30.0 28.0±23.3
Osteoprotegerin [pmol/l] 7.3±5.81 8.2±4.3 7.2±4.9 7.9±5.84 9.5±6.41 7.4±5.7 7.3±5.6
MGP [ng/ml] 103.7±30.4 62.0±28.44 93.2±44.2 85.8±39.21 97.4±58.6 102.1±38.4 95.7±43.4
  1. 1 p<0.01; 2 p<0.0001; 3 p=0.065; 4 p<0.05; 5 p<0.07; 6 p<0.08